Cargando…

Intensive Blood Pressure Control, APOL1 Genotype, and Kidney Outcomes in Individuals With Type 2 Diabetes: A Post Hoc Analysis of the Action to Control Cardiovascular Risk in Diabetes-Blood Pressure (ACCORD-BP) Trial

Detalles Bibliográficos
Autores principales:	Dinh, Alex, Copeland, Timothy, Freedman, Barry I., McCulloch, Charles E., Ku, Elaine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515080/ https://www.ncbi.nlm.nih.gov/pubmed/34693269 http://dx.doi.org/10.1016/j.xkme.2021.04.020

Ejemplares similares

Additive effects of intensive BP control and ACE inhibition on suppression of proteinuria in patients with CKD
por: Lopez, Rafael, et al.
Publicado: (2023)

Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes
por: Ku, Elaine, et al.
Publicado: (2016)

Association of APOL1 Genotypes With Measures of Microvascular and Endothelial Function, and Blood Pressure in MESA
por: Chen, Teresa K., et al.
Publicado: (2020)

Erratum. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733–1738
por: Buckley, Leo F., et al.
Publicado: (2018)

APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial
por: Freedman, Barry I., et al.
Publicado: (2017)

Effect of Intensive Glycemic and Blood Pressure Control on QT Prolongation in Diabetes: The ACCORD Trial
por: Singleton, Matthew J., et al.
Publicado: (2020)

Value of ambulatory blood pressure measurement in diagnosing hypotension in hypertensive diabetic patients with medication-controlled BP
por: Alghalayini, Kamal
Publicado: (2020)

bp: Blood pressure analysis in R
por: Schwenck, John, et al.
Publicado: (2022)

Insufficient Control of Blood Pressure and Incident Diabetes
por: Izzo, Raffaele, et al.
Publicado: (2009)

Target: BP™: A National Initiative to Improve Blood Pressure Control
por: Smith, Alison P., et al.
Publicado: (2023)

Restricted Mean Survival Time in Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure
por: Shi, Sandra, et al.
Publicado: (2020)

Effect of Blood Pressure Control on Long‐Term Risk of End‐Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease
por: Ku, Elaine, et al.
Publicado: (2019)

Intensive Blood Pressure Treatment Does Not Improve Cardiovascular Outcomes in Centrally Obese Hypertensive Individuals With Diabetes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial
por: Barzilay, Joshua I., et al.
Publicado: (2012)

Weight Change in Diabetes and Glycemic and Blood Pressure Control
por: Feldstein, Adrianne C., et al.
Publicado: (2008)

Blood pressure control in type 2 diabetic patients
por: Grossman, Alon, et al.
Publicado: (2017)

Blood Pressure Control in Patients with Diabetic Kidney Disease
por: Kim, Yaeni, et al.
Publicado: (2022)

Should kidney donors be genotyped for APOL1 risk alleles?
por: Freedman, Barry I., et al.
Publicado: (2015)

Intensive Blood Pressure Control and Diabetes Mellitus‐Related Limb Events in Patients With Type 2 Diabetes Mellitus: Reanalysis of ACCORD
por: Tran, Kenneth, et al.
Publicado: (2021)

Antihypertensive drug effects according to the pretreatment self-measured home blood pressure: the HOMED-BP study
por: Sano, Hikari, et al.
Publicado: (2020)

Glycaemic, blood pressure and cholesterol control in 25 629 diabetics
por: Pinchevsky, Y, et al.
Publicado: (2015)

Control of Blood Pressure and Cardiovascular Outcomes in Type 2 Diabetes
por: Vargas-Uricoechea, Hernando, et al.
Publicado: (2018)

Effect on Glycemic, Blood Pressure, and Lipid Control according to Education Types
por: Choi, Mi-Ju, et al.
Publicado: (2011)

The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension
por: Beckett, Linda, et al.
Publicado: (2005)

Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
por: Huang, Chenxi, et al.
Publicado: (2017)

Blood Pressure and Diabetic Nephropathy
por: Bloomgarden, Zachary T.
Publicado: (2010)

Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: a post hoc analysis (ORIENT-blood pressure)
por: Imai, Enyu, et al.
Publicado: (2016)

Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
por: Liu, Jie, et al.
Publicado: (2019)

Reaching an ACCORD on Glycemia and Systolic Blood Pressure Targets in Type 2 Diabetes Mellitus
por: MacDonald, Thomas M., et al.
Publicado: (2018)

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT
por: Beddhu, Srinivasan, et al.
Publicado: (2018)

Supporting blood pressure measurement prior to online prescription of the combined oral contraceptive
por: Baraitser, Paula, et al.
Publicado: (2021)

Response to Comment on Chan et al. FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes. Diabetes Care 2018;41:178–186
por: Divers, Jasmin, et al.
Publicado: (2018)

The Paraventricular Nucleus of the Hypothalamus in Control of Blood Pressure and Blood Pressure Variability
por: Savić, Bojana, et al.
Publicado: (2022)

The Central Control of the Blood Pressure
por: Werner, G.
Publicado: (1953)

Impact of telemetry supported home blood pressure monitoring: experiences of patients and professionals participating in the HITS randomised controlled trial of telemetry enabled home blood pressure (BP)
por: Hanley, Janet, et al.
Publicado: (2012)

Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (Prevention After Stroke—Blood Pressure) randomised controlled trial
por: Mant, Jonathan, et al.
Publicado: (2016)

An assessment of discriminatory power of office blood pressure measurements in predicting optimal ambulatory blood pressure control in people with type 2 diabetes
por: Kengne, Andre Pascal, et al.
Publicado: (2014)

Renoprotection, renin inhibition, and blood pressure control: the impact of aliskiren on integrated blood pressure control
por: Rashid, Haroon-Ur
Publicado: (2010)

Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
por: Chamberlain, Alanna M., et al.
Publicado: (2023)

Design and Rationale of the Home Blood Pressure Telemonitoring Linked with Community Health Workers to Improve Blood Pressure (LINKED-BP) Program
por: Commodore-Mensah, Yvonne, et al.
Publicado: (2023)

Improving Blood Pressure Control in Patients with Diabetes Mellitus and High Cardiovascular Risk
por: Elliott, Henry L., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_25e41vl30lol5lbic7scu3sjvi